Developments in Nephrology

I. Glomerulonephritis.- Modulation of endothelial barrier and coagulant properties by hypoxia.- Cellular immunity in glomerular pathology primarily induced by immune-complexes.- Immunosuppressive treatment of autoimmune nephropathies.- Effect of proteinase inhibitor Camostat Mesilate on nephrotic syndrome.- Treatment of nephrotic hyperlipidemia.- Effect of PSK administration followed by initial prednisolone therapy in the steroid responsive idiopathic nephrotic children.- Zinc therapy for minimal change nephrotic syndrome and its effect on IgG synthesis.- The nephrotic syndrome in the elderly: epidemiological data.- Antiaggregating platelet therapy in chronic glomerulonephritis (GN).- Membranoproliferative glomerulonephritis type I: a correlation between treated (138) and untreated (108) patients.- Methylprednisolone (MP) pulse therapy in childhood IgA nephropathy.- Immunosuppressive treatment of Berger's disease.- High dose intravenous human IgG in the treatment of idiopathic membranous nephropathy: preliminary report of a multicentric trial.- Treatment of patients with membranous nephropathy (MN).- Anticoagulant therapy and steroid pulse therapy to rapidly progressive IgA nephropathy.- Contemporary treatment of idiopathic membranous glomerulonephritis.- Effect of methylprednisolone pulse therapy in patients with Lupus Nephritis assessed by WHO morphologic classification.- Effect of Dilazep dihydrochloride (DZ) therapy in patients with chronic glomerulonephritis.- Follow-up of treated patients with primitive membranous nephritis.- Role of ACE inhibition in IgA nephropathy.- Early indicators of renal disease in parenteral substance abusers.- Platelet derived growth factor and interleukin-1 expression are increased in murine IgA nephropathy.- Effect of cyclosporine A on the anionic sites in the glomerular basement membrane of Puromycin nephrotic rats.- Therapeutic approach for the deteriorated renal function in IgA nephropathy.- IgA nephropathy and cytomegalovirus.- Intestinal permeability and antibodies against dietary antigens in IgA nephropathy.- Parameters affecting the poor prognosis of IgA nephropathy -a clinical study.- Successful induction of seroconversion and diminished proteinuria in 3 cases of hepatitis B virus (HBV) associated glomerulonephritis.- Goodpasture's syndrome: a clinical case.- Effects of Piretanide on renal function and the ANP/RAA-system in patients with the nephrotic syndrome.- Inhibition of the hydroxyl radical by dimethylthiourea and proteinuria in adriamycin experimental nephrosis.- Late treatment with Captopril worsens the course of Adriamycin nephropathy in rats.- II. Acute Renal Failure.- Acute renal failure after poisoning with concentrated acetic acid.- Daily recycled bicarbonate dialysis in treatment for acute renal failure in critically ill patients.- Endotoxin stimulates synthesis of platelet activating factor via production of tumor necrosis factor by human mesangial cells.- Reversible acute renal failure in Lupus Nephritis due to a hypertensive crisis.- Early effects of acute obstruction of biliary duct in the rat.- III. Chronic Renal Failure.- Treatment of hypertension in chronic renal failure. p.- Geographical distribution of the unknown aetiology end-stage renal failure in Greece.- Valuation of the immunological parameters in chronic renal insufficient patients with or without haemodialytic treatment.- Chronic renal failure (CRF) and lipidemic parameters.- The effect of cimetidine on parathyroid in the uremic patients.- Bone GLA protein in chronic renal failure.- Cystic diseases in uremia and HLA system.- Cardiac morphology evaluation in patients with chronic renal failure: an echocardiographic study.- ANP in chronic renal failure is related to plasma creatinine but not to blood pressure or dialysis.- Correlation of biochemical and histological indices of renal osteodystrophy in patients with mild to moderate chronic renal failure.- Does Indomethacin in Bartter's syndrome interfere with the membrane receptors for GH.- IV. Diabetic Nephropathy.- Advanced glycosylation end products: interactions with cells.- Antihypertensive treatment and evolution of incipient nephropathy in type II diabetic patients. A 30 month follow up.- Beneficial effect of dipyridamole on proteinuria in diabetic nephropathy.- Renal functional reserve (RFR) in patients with short term type I diabetes mellitus (DM1) without nephropathy.- Diabetic nephropathy: prevalence and risk factors.- The terminal complement complex (TCC) in the plasma of patients with type I diabetes mellitus. Relationship with albumin excretion rate.- Microalbuminuria and renal lesions in diabetic nephropathy.- Effect of dietary protein restriction on the progression of renal damage in diabetic nephropathy.- Diabetic nephropathy in outpatients with type 2 (non insulin-dependent) diabetes.- Prevalence of diabetic nephropathy in a single region: changes in acceptance rates in the last 8 years..- Arterial hypertension (AH) and microalbuminuria (MA) in patients with type 2 diabetes mellitus.- "Incipient" nephropathy, serum apolipoproteins and blood pressure levels in type 1 diabetes.- ACE inhibitors of diabetic nephrosis.- Radioisotopical studies of the glomerular filtrate in a group of insulin-dependent diabetics.- Diabetic nephropathy in type 2 (non insulin-dependent) diabetes: a cross-sectional study.- V. Hypertension.- Nifedipine versus Captopril in the treatment of severe hypertension of diabetic patients.- Effects of rHuEPO on the aldosterone secretion -an in vivo and in vitro study.- Efficacy and tolerability of Cilazapril (CLZ) in hypertensive patients (PTS) with chronic renal failure (CRF).- Long term results of renal angioplasty in patients with renovascular hypertension.- Nitrendipine in patients with end-stage renal disease and hypertension.- First choice treatment of dialysis-resistant hypertension: a crossover comparison of single oral dose of Captopril and Nifedipine.- Clinical study of Bunazosin treatment for patients with renal hypertension.- Vasodilatory prostaglandins and loop diuretics.- Systemic hypertension in 5/6 nephrectomized rats does not affect the changes caused by Low protein intake.- Diltiazem: its antihypertensive activity without renal effects in man.- Effects of Piretanide on sodium and potassium excretion and on renal hemodynamics.- VI. Dialysis.- How to improve biocompatibility in dialysis.- Captopril treatment of hypertensive patients on maintenance hemodialysis.- Importance of volume factors in dialysis-related hypertension.- Effects of different hemodialysis (HD) methods on the nutritional status of HD patients (pts).- Urea kinetic parameters in haemodialysis patients treated with erythropoietin.- Continuous ambulatory peritoneal dialysis as an alternative therapy to metal removal with Desferrioxamine B.- Endogenous hyperphosphatemia in patients treated with maintenance hemodialysis.- Prostacyclin in haemodialysis.- Atrial natriuretic factor, B-endorphin, parathyroid hormon and recombinant human erythropoietin in haemodialysis patients.- Altered membrane transport of choline in renal failure: a comparison of non-dialysed and haemodialysed patients.- Direct inhibitory effect of intravenous Calcitriol on parathyroid function in hemodialysis patients.- Maxillary "Giant Cell Brown Tumor" (GCBT) in a patient on maintenance hemodialysis (HD) with secondary hyperparathyroidism (SHPT): case report.- Prevention of thrombosis of vascular prosthesis in hemodialysis: effect of long-term treatment with urokinase at the end of the dialytic session.- Free erythrocyte protoporphyrin in hemodialysis patients treated with human recombinant erythropoietin.- The value of Desferrioxamine (DFO) test in accidental acute Aluminum overload in hemodialysis. Six months later, the influence of DFO treatment.- Comparative efficacy of two different intravenous dosages of recombinant human erythropoietin (rHuEPO) in the anemia of haemodialysis. Effects on iron stores.- Dialysis and urine flow.- Bone metabolism parameters in patients undergoing intravenous Calcitriol treatment.- Effect of Deferoxamine on Aluminum kinetics during hemodialysis.- Is zero net peritoneal ultrafiltration (Net UF) a desirable aim in CAPD.- Could secondary hyperparathyroidism influence the response to hepatitis B vaccination of hemodialyzed patients.- Recombinant human erythropoietin R-HuEPO, effective treatment in correction the anemia of patients in hemodialysis (HD).- Anti-HCV in HD: a preliminar report.- Effects of hemodialysis on cerebral blood velocity in uremic patients.- Acetate free biofiltration (A.F.B.): 12 months of experience.- Calcium carbonate (CaCO3) as a phosphate binder in patients on renal replacement therapy.- Classical and Alternative pathway complement activity in hemodialysis and CAPD patients.- Thrombotic risk during r-EPO therapy in hemodialized patients. A new hypothesys.- Improvement of treatment compatibility in dialysis by blood volume controlled ultrafiltration.- Continuous control of blood volume changes during hemodialysis and its implication for the determination of an optimal ultrafiltration-rate.- Computer modulated profile haemodialysis (CMP-HD) and vasoactive hormones.- Improvement of paired filtration dialysis (PFD) for optimum removal of small and large molecules.- Paired filtration dialysis (PFD). Spanish multicentric study.- Comparison of effects of erythropoietin (r-HuEPO) in patients on hemodiafiltration (HDF) vs conventional hemodialysis (SD).- Continuous ultrasonic measurement of whole blood protein concentration for the assessment of relative blood volume changes during hemodialysis.- Computer-modulated profile hemodialysis (CMP-HD) versus standard bicarbonate hemodialysis (BIC-HD).- New strategies enhance the role of peritoneal dialysis in renal replacement therapy.- Steady-state blood and tissue plasticizer concentration: in vivo comparison between DOP (DEHP) and TOT (TEHT).- Paired filtration dialysis (PFD): biocompatibility and depurative efficiency.- Myoglobin (MYO) removal by highly permeable polymethylmetacrylate (PMMA) in rhabdomyolysis -induced acute renal failure (RH-ARF).- Bicarbonate and calcium kinetics during paired filtration dialysis (PFD).- VII. Renal Replacement Therapy in Children.- Continuous ambulatory peritoneal dialysis (CAPD): The treatment of choice in paediatric chronic renal failure (CRF).- CAPD is not the best treatment for children with ESRD: a retrospective study of 23 patients who received both CAPD and hemodialysis.- Risk-orientated preparation of uremic children for renal transplantation.- Growth in children on long-term dialysis.- Carnitine (C) metabolism in renal insufficient and regular hemodialyzed children.- VIII. Renal Replacement Therapy in Diabetic Patients.- What dialysis is best for diabetic patients-hemodialysis or CAPD.- Peritoneal versus extra-corporeal dialysis for diabetic uremic patients: where do we stand in the early nineties.- Renal replacement therapy in diabetic patients.- The treatment of uremic diabetic patients (UDP) in Piemonte (dialysis and transplantation registry - RPDT): survival analysis.- Diabetes and renal replacement therapy in Italy: mode of treatment and major complications.- Renal transplantation (RT) in diabetic nephropathy (DN) in the 80's decade.- Dialytic treatment of diabetic patients with end -stage renal failure: 17 years of experience.- Analysis of a cohort of diabetics on dialysis: clinical and rehabilitation features related to dialysis age.- Relative risk of death in diabetic and non diabetic dialysis pts: a useful marker of a cohort features.- Chronic complications in diabetic hemodialyzed patients.- Impendance cardiographic evaluation of the central hemodynamic in diabetic patients treated with maintenance hemodialysis /HD.- A single-institution experience in 15-year dialysis treatment of diabetic patients.- IX. Transplantation.- Monoclonal antibodies OKT3 in resistant acute allograft rejections treatment.- Pancreas transplantation today: indications, techniques, and results in over 160 cases.- Determination of gamma Interferon and Neopterin serum levels for graft monitoring.- Xenogeneic transplantation: immunologic issues and future prospects.- The role of fine needle aspiration biopsy in the diagnosis of acute rejection in early and late post-transplant monitoring.- Temporary double-J stenting of the ureter following renal transplantation.- Acute phase response during monoclonal antibody treatment-relationship to antimonoclonal sensitization.- Protective effect of calcium-channel blockers on the cyclosporine (CyA)-related nephrotoxicity.- Lipid and Apoprotein profile in renal transplant recipients.- Thyroid function after renal transplantation.- Simultaneous pancreas-kidney transplantation: early detection of rejection by amylasuria determination.- Echo doppler sonography of the renal allograft acute rejection.- Renal hemodynamic effects of short-term therapy with low doses of cyclosporine A (CsA) in humans with intact kidney.- Modifications of plasma volume and ANF during long-term administration of cyclosporine.- Clinical implications of unexpected high glomerular filtration rate after renal transplantation.- Influence of HLA- class II on graft survival in patients with low cyclosporine doses.- Recurrence of focal glomerulosclerosis (FGS) following renal transplantation.- Author index.